New award for metoprolol succinate tablets with DR. Reddys laboratories. Ordering period is april 29, 2026 to april 28, 2027 with four on-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79726D0011
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 52% complete
IDV ceiling
$34,174,868.13
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to DR Reddy's Laboratories, Inc. for Metoprolol Succinate Tablets, with a ceiling of $34,174,868.13, effective April 29, 2026. The contract carries a one-year base period running through April 28, 2027, followed by four one-year options extending potential performance through April 2031.

The procurement is unrestricted with no set-aside designation and operates under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The contract serves multiple federal agencies—the VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center—with distribution through the VA's and DoD's Pharmaceutical Prime Vendor Programs.

The originating RFP 36E79725R0058, posted August 25, 2025, sought supply of Metoprolol Succinate Sustained Action tablets across multiple dosage strengths (25mg, 50mg, 100mg, and 200mg) in package configurations of 100, 500, and 1,000 tablets per bottle. Offerors were required to provide the exact drug name as labeled, maintain a unique NDC number specific to the offeror, and ensure their label was the only one affixed to the product. The solicitation incorporated Executive Order 14398 diversity and nondiscrimination provisions.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · Implementing EO 14398 DEI discrimination $0
Add Subcontract Plan P00003 · This modification is issued to incorporate DR. Reddy's laboratories, INC.'S 2027 subcontracting plan effective for the $0
Supplemental Agreement for work within scope P00002 · This bilateral modification is issued to resume performance on national contract 36E79726D0011. $0
Supplemental Agreement for work within scope P00001 · This bilateral modification is issued to suspend performance on national contract 36E79726D0011, due to an agency protest of this award. $0
Original award $0

Quick answers

Who was awarded contract 36E79726D0011?

36E79726D0011 was awarded to DR Reddy's Laboratories, Inc. by National Acquisition Center (Headquarters) on April 29, 2026.

How much is contract 36E79726D0011 worth?

36E79726D0011's own ceiling is $34,174,868.

Who can order from contract 36E79726D0011?

36E79726D0011 is a single award indefinite delivery contract.

Was contract 36E79726D0011 competed?

The extent of competition for 36E79726D0011 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV